HBE1 and thalassemia: As deoxygenated hemoglobin in erythrocytes can catalyze nitrite reduction to NO resulting in platelet inhibition [15], it is possible that the reduced rate of HbE-mediated production of NO may be a factor in aggravating platelet activation, a key event leading to thrombosis and vascular complications in HbE/ß-thalassemia.